Camber Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33M | Buy |
|
|||||
|
2025
Q1 | $35.3M | Buy |
|
|||||
|
2024
Q4 | $29.6M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $90.6M | Buy |
|
|||||
|
2024
Q1 | $21.8M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $26.5M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $67.8M | Sell |
|
|||||
|
2022
Q2 | $124M | Buy |
|
|||||
|
2022
Q1 | $100M | Buy |
|
|||||
|
2021
Q4 | $89.7M | Sell |
|
|||||
|
2021
Q3 | $88.9M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $30.4M | Buy |
|